Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond.
Saved in:
| Title: | Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond. |
|---|---|
| Authors: | Zhao Y; State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.; Beijing Institute for Stem Cell and Regenerative Medicine, Beijing, China., Du J; Department of General Surgery, The 7th Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China., Shen X; Department of General Surgery, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China. |
| Source: | Frontiers in immunology [Front Immunol] 2023 Mar 17; Vol. 14, pp. 1157537. Date of Electronic Publication: 2023 Mar 17 (Print Publication: 2023). |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
